Dormant cytomegalovirus resides in eyes of healthy mice long after infection

May 31, 2018, Public Library of Science
Cytomegalovirus infected cells surrounding iris vessels. Credit: Dr. Valentina Voigt

Infection with cytomegalovirus triggers long-lasting eye inflammation and establishes a dormant pool of the virus in the eyes of mice with healthy immune systems, according to new research presented in PLOS Pathogens by Valentina Voigt of the Lions Eye Institute in Western Australia and colleagues.

Cytomegalovirus infects more than half of all adults by the age of 40, but causes symptoms only in people with compromised immune systems. After a person is infected, the virus persists life-long in a dormant state. In people with healthy immune systems, reservoirs of latent were thought to exist in tissues such as lung and salivary gland, but recent evidence hints that they may also occur in tissues thought to be protected by the immune system, including the eyes.

To determine whether cytomegalovirus can access the eyes of hosts with healthy immune systems, Voigt and colleagues performed a series of experiments in mice. They infected the animals with a mouse version of cytomegalovirus and used various imaging and molecular techniques to examine the effects of the pathogen on the eye.

The researchers found that cytomegalovirus indeed infected the iris, but not the retina, of the mouse eye. The also caused chronic inflammation of the iris and retina that persisted for months; long after the scientists could no longer detect replicating cytomegalovirus in the eye. Latent cytomegalovirus taken from the eyes 70 days post- could be reactivated and begin to replicate in a dish.

"Since the mouse model of cytomegalovirus infection faithfully recapitulates most of the pathologies seen in people after infection with human cytomegalovirus, this study represents an important advance in understanding the full impact of this infection, especially in healthy subjects" says study co-author Mariapia Degli-Esposti.

While more research is needed to determine whether these unexpected findings extend to humans, they suggest that researchers and doctors may need to rethink the effects of cytomegalovirus—and, potentially, other viruses—on the eyes. Some eye problems caused by dormant or reactivated cytomegalovirus in people with healthy immune systems may be misdiagnosed, leading to improper treatment that could damage vision.

Explore further: Immune cells promote or prevent cytomegalovirus activity in mice depending on location

More information: Voigt V, Andoniou CE, Schuster IS, Oszmiana A, Ong ML, Fleming P, et al. (2018) Cytomegalovirus establishes a latent reservoir and triggers long-lasting inflammation in the eye. PLoS Pathog 14(5): e1007040. doi.org/10.1371/journal.ppat.1007040

Related Stories

Immune cells promote or prevent cytomegalovirus activity in mice depending on location

August 10, 2017
Immune system cells called regulatory T cells appear to promote cytomegalovirus (CMV) latency in the spleen of mice, but suppress it in the salivary gland. Maha Almanan of the University of Cincinnati College of Medicine, ...

Scientists ID human protein essential for human cytomegalovirus replication

May 11, 2017
Scientists have demonstrated that a human protein known as valosin containing protein (VCP) is essential for replication of human cytomegalovirus (HCMV). The findings, published in PLOS Pathogens, identify VCP as a potential ...

HIV-positive women with cytomegalovirus likelier to pass virus that causes AIDS to infant

June 22, 2017
HIV-positive women with cytomegalovirus, or CMV, in their urine at the time of labor and delivery are more than five times likelier than HIV-positive women without CMV to transmit HIV, the virus that causes AIDS, to their ...

Origin of chronic lymphatic leukaemia: lead discovered

April 11, 2012
Up until now the causes of the development of chronic lymphatic leukaemia, the most common form of cancer of the blood in Europe, have been unknown. At present a cure is not possible. A research group at the MedUni Vienna ...

Cytomegalovirus hijacks human enzyme for replication

March 23, 2015
More than 60 percent of the world's population is infected with a type of herpes virus called human cytomegalovirus. The virus replicates by commandeering the host cell's metabolism but the details of this maneuver are unclear.

Psychiatric medication protects developing mouse brain from birth defects

June 19, 2017
A clinically available anxiety drug safely and effectively protects against brain defects caused by the mouse version of a common human virus, finds new research published in The Journal of Neuroscience.

Recommended for you

New way of determining treatment for staph infections cuts antibiotic use

September 25, 2018
Using a clinical checklist to identify eligible patients, doctors were able to shorten the antibiotic duration for patients with uncomplicated staphylococcal bloodstream infections by nearly two days, Duke Health researchers ...

Breakthrough in designing a better Salmonella vaccine

September 24, 2018
UC Davis researchers announce in the Proceedings of the National Academy of Sciences this week a breakthrough in understanding which cells afford optimal protection against Salmonella infection—a critical step in developing ...

Antifungal agent found to be possible treatment for porphyria

September 24, 2018
A large team of researchers from Spain, France and the U.S. has found that a common antifungal agent might be useful as a treatment for a rare type of porphyria. In their paper published in the journal Science Translational ...

New findings on the muscle disease Laing early-onset distal myopathy

September 24, 2018
New avenues are now being opened toward treatment of Laing distal myopathy, a rare disorder that causes atrophy of the muscles in the feet, hands and elsewhere. In a study published in the journal PNAS, researchers have identified ...

Insulin shows great potential against chronic colitis

September 24, 2018
Diabetes is not the only disease on which insulin has an effect, it appears. In a new study using tests on mice, researchers from the University of Copenhagen, among others, have discovered a new method for treating chronic ...

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.